Clinical Trial Update: Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy

View source ↗

Summary

Long-term follow-up of subjects with Sickle Cell Disease treated with an ex vivo gene therapy; enrollment by invitation is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Genetix ex vivo gene therapy

Snippet

Sponsor: Genetix Biotherapeutics Inc. | Conditions: Sickle Cell Disease | Status: ENROLLING_BY_INVITATION